| Serial Number | 77688851 |
| Word Mark | TRANSFIGURE |
| Filing Date | Wednesday, March 11, 2009 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Thursday, August 13, 2020 |
| Registration Number | 3686000 |
| Registration Date | Tuesday, September 22, 2009 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 7, 2009 |
| Goods and Services | Evaluation of the credit worthiness of companies and private individuals; Leveraged buy outs and investments in financially distressed or underperforming companies; Trust services, namely, investment and trust company services; Venture capital funding services to emerging and start-up companies; Venture capital services, namely, providing financing to emerging and start-up companies |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Administrative processing of purchase orders within the framework of services provided by mail-order companies; An interactive web site for users to review and rate internet content, people, companies, products and/or services utilizing a software application to award points whereby web site users are eligible to exchange points earned for promotional items consisting of coupons, rebates, discounts or special offerings on goods and/or service provided by web site sponsors; Arranging the transport of vehicles of insured parties on behalf of their insurance companies for resolution of insurance claims; Audit support services, namely, review and analysis of a company's sales, as well as the preparation, organization and presentation of the documents and data requested by a government body, and advice on government audit processes, policies and strategy; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business information services, namely, gathering and reporting information regarding e-mail addresses of others that are made available to other companies for commercial purposes; Business management assistance for industrial or commercial companies; Business management consulting with relation to strategy, financing, marketing, production, personnel and sale matters for companies involved with thin film and nano technologies and plasma processes; Business management services, namely, purchasing of and selling of companies for others; Company management, including consultancy in demographic matters; Consultation services in the field of company, business sector and industry data and research; Creation of marketing tools designed to increase a client company's knowledge of customer needs, and its competitors' products and services, pricing, advertising strategy and sales strategy; Economic consulting and information for the industrial and commercial sectors for planning, organizing, monitoring and carrying out unique and complex projects in different sectors of one or several companies; Fund raising for others for the purpose of purchasing companies; Information and expert opinions relating to companies and business; Lobbying services, namely, promoting the interests of international, real estate and nonprofit companies in the fields of politics, legislation, and regulation; Management of an airline company; Marketing and branding services, namely, performing consumer insight and brand strategy of company logos; Processing energy utility customer rebates for utility companies; Providing a live forum for companies to showcase, display, demonstrate and promote new and innovative ideas, products and services in the convention/meeting management arena; Providing an interactive web site for persons to register complaints against companies and/or services of all types; Providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Thursday, August 13, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | Monday, August 22, 2005 |
| First Use In Commerce Date | Monday, August 22, 2005 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Thursday, August 13, 2020 |
| Primary Code | 036 |
| First Use Anywhere Date | Monday, August 22, 2005 |
| First Use In Commerce Date | Monday, August 22, 2005 |
| Party Name | Transfigure Investments, llc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Anchorage, AK 99519 |
| Party Name | Transfigure Investments, llc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Anchorage, AK 995161890 |
| Party Name | Transfigure Investments, llc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Anchorage, AK 995161890 |
| Event Date | Event Description |
| Saturday, April 9, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Saturday, April 9, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Saturday, April 9, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, May 3, 2021 | PETITION TO DIRECTOR DENIED |
| Tuesday, March 9, 2021 | ASSIGNED TO PETITION STAFF |
| Tuesday, September 22, 2020 | TEAS PETITION TO DIRECTOR RECEIVED |
| Friday, August 14, 2020 | NOTICE OF CANCELLATION SEC. 8 EMAILED |
| Thursday, August 13, 2020 | CANCELLED SEC. 8 (10-YR) |
| Wednesday, February 12, 2020 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| Tuesday, February 4, 2020 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Wednesday, September 4, 2019 | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
| Thursday, August 29, 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, August 23, 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, August 23, 2019 | TEAS SECTION 8 & 9 RECEIVED |
| Saturday, September 22, 2018 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Wednesday, October 1, 2014 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
| Wednesday, October 1, 2014 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| Monday, September 29, 2014 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, September 22, 2014 | TEAS SECTION 8 RECEIVED |
| Monday, September 22, 2014 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 22, 2009 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 7, 2009 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 17, 2009 | NOTICE OF PUBLICATION |
| Thursday, June 4, 2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, June 4, 2009 | ASSIGNED TO LIE |
| Tuesday, June 2, 2009 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 2, 2009 | ASSIGNED TO EXAMINER |
| Monday, March 16, 2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, March 14, 2009 | NEW APPLICATION ENTERED IN TRAM |